Using deep learning to predict mild cognitive impairment and Alzheimer's dementia
Deep learning for prediction of Mild Cognitive Impairment and Dementia of the Alzheimer's type
['FUNDING_R21'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10846599
This study is working on a smart computer program that looks at brain scans to help doctors spot early signs of mild cognitive impairment and Alzheimer's, so they can provide better care for patients like you.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10846599 on ClinicalTrials.gov |
What this research studies
This research aims to develop a deep learning model that analyzes functional neuroimaging data to better understand and predict mild cognitive impairment and Alzheimer's dementia. By leveraging large datasets and advanced computational techniques, the project seeks to identify patterns in brain activity that can indicate the presence of these conditions. The approach focuses on creating a system that can generalize across different individuals and conditions, making it applicable to a wide range of patients. This innovative methodology could lead to earlier and more accurate diagnoses, ultimately improving patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those showing early signs of cognitive decline or at risk for Alzheimer's disease.
Not a fit: Patients with advanced Alzheimer's disease or other forms of dementia may not benefit from this research as it focuses on early detection.
Why it matters
Potential benefit: If successful, this research could enable earlier detection and better management of Alzheimer's disease and related dementias.
How similar studies have performed: Previous research using deep learning in neuroimaging has shown promise, indicating that this approach could be effective in predicting cognitive decline.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PELTIER, SCOTT JAMES — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: PELTIER, SCOTT JAMES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome